LS Investment Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,157
Closed -$95K 1596
2020
Q2
$95K Buy
2,157
+112
+5% +$4.18K 0.01% 998
2020
Q1
$73K Hold
2,045
0.01% 1006
2019
Q4
$145K Hold
2,045
0.01% 965
2019
Q3
$153K Buy
2,045
+94
+5% +$7.97K 0.01% 900
2019
Q2
$157K Sell
1,951
-95
-5% -$6.68K 0.01% 900
2019
Q1
$137K Sell
2,046
-80
-4% -$6.06K 0.01% 957
2018
Q4
$158K Sell
2,126
-693
-25% -$57.2K 0.01% 847
2018
Q3
$260K Sell
2,819
-211
-7% -$20.1K 0.02% 737
2018
Q2
$298K Sell
3,030
-7
-0.2% -$783 0.02% 699
2018
Q1
$338K Buy
3,037
+995
+49% +$112K 0.02% 644
2017
Q4
$210K Sell
2,042
-380
-16% -$37.9K 0.01% 867
2017
Q3
$228K Buy
2,422
+209
+9% +$16.5K 0.01% 875
2017
Q2
$172K Hold
2,213
0.01% 954
2017
Q1
$177K Buy
2,213
+669
+43% +$53.2K 0.01% 896
2016
Q4
$122K Buy
1,544
+9
+0.6% +$699 0.01% 980
2016
Q3
$120K Buy
1,535
+25
+2% +$1.81K 0.01% 954
2016
Q2
$104K Buy
1,510
+106
+8% +$7.31K 0.01% 986
2016
Q1
$100K Buy
1,404
+66
+5% +$4.14K 0.01% 880
2015
Q4
$83K Hold
1,338
0.01% 936
2015
Q3
$76K Hold
1,338
0.01% 971
2015
Q2
$72K Buy
+1,338
New +$65.1K 0.01% 1023

Other funds holding CMD

LS Investment Advisors's CMD Position: Q3 2020 in Review

LS Investment Advisors sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 2,157 shares — an estimated $95K sold.

LS Investment Advisors first reported a position in CMD in Q2 2015 and held it in 21 quarters. The position peaked at $338K in Q1 2018. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

  • LS Investment Advisors reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 2,157 Cantel Medical Corporation shares in Q3 2020, an estimated $95K.
  • LS Investment Advisors first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 21 quarters.
  • LS Investment Advisors's Cantel Medical Corporation position peaked at $338K in Q1 2018.
  • 196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.